Correlation Between Evoke Pharma and Alzamend Neuro

Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Alzamend Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Alzamend Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Evoke Pharma and Alzamend Neuro, you can compare the effects of market volatilities on Evoke Pharma and Alzamend Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Alzamend Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Alzamend Neuro.

Diversification Opportunities for Evoke Pharma and Alzamend Neuro

0.65

Correlation Coefficient

Evoke Pharma  Alzamend Neuro

Poor diversification

The 3 months correlation between Evoke and Alzamend is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Alzamend Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alzamend Neuro and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Alzamend Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alzamend Neuro has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Alzamend Neuro go up and down completely randomly.

Pair Corralation between Evoke Pharma and Alzamend Neuro

Given the investment horizon of 90 days Evoke Pharma is expected to under-perform the Alzamend Neuro. But the stock apears to be less risky and, when comparing its historical volatility, Evoke Pharma is 1.09 times less risky than Alzamend Neuro. The stock trades about -0.23 of its potential returns per unit of risk. The Alzamend Neuro is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  119.00  in Alzamend Neuro on October 25, 2024 and sell it today you would lose (1.00) from holding Alzamend Neuro or give up 0.84% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Evoke Pharma  vs.  Alzamend Neuro

Evoke Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Evoke Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Alzamend Neuro

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Alzamend Neuro has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Evoke Pharma and Alzamend Neuro

The main advantage of trading using opposite Evoke Pharma and Alzamend Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Alzamend Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will offset losses from the drop in Alzamend Neuro's long position.

The idea behind Evoke Pharma and Alzamend Neuro pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.